Construction of PARPi Resistance-related Competing Endogenous RNA Network

Objective: Ovarian cancer is a kind of common gynecological malignancy in women. PARP inhibitors (PARPi) have been approved for ovarian cancer treatment. However, the primary and acquired resistance have limited the application of PARPi. The mechanisms remain to be elucidated. Methods: In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Lili, Xu, Jiaqi, Yu, Lijun, Liu, Shuo, Liu, Zongjian, Xiang, Juanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Genetics & Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875538/
https://www.ncbi.nlm.nih.gov/pubmed/36777878
http://dx.doi.org/10.2174/1389202923666220527114108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875538/
https://www.ncbi.nlm.nih.gov/pubmed/36777878
http://dx.doi.org/10.2174/1389202923666220527114108

Ejemplares similares